Board Meeting11 Aug 2026, 01:25 pm
Zydus Lifesciences Declares Unaudited Q1 FY27 Results
AI Summary
Zydus Lifesciences Limited announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results, which were reviewed by the Audit Committee and the Statutory Auditors, Deloitte Haskins & Sells LLP. The company also informed about the closure and reopening of the trading window for its directors and designated persons.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Results approved by the Board of Directors.
- Standalone and consolidated results reviewed by auditors.
- Trading window closure and reopening dates announced.
Price Impact
More from ZYDUSLIFE